Patel K B, Nicolau D P, Nightingale C H, Quintiliani R
Department of Pharmacy Practice, Arnold and Marie Schwartz College of Pharmacy, Long Island University, Brooklyn, New York 11201, USA.
Antimicrob Agents Chemother. 1996 Dec;40(12):2805-8. doi: 10.1128/AAC.40.12.2805.
In a randomized crossover study involving 12 healthy volunteers, 1 g of ceftizoxime or cefotaxime was administered intravenously every 12 h for a total of three doses on two separate weekends. The duration of serum bactericidal titers (SBTs) greater than 1:2 and the time serum drug concentrations remained above the MIC (T > MIC) were determined against three clinical isolates of Streptococcus pneumoniae with intermediate resistance to penicillin. The duration of SBTs and T > MIC for both antimicrobial agents exceeded 50% of the dosing interval for all isolates. Ceftizoxime's T > MIC was statistically greater than that of cefotaxime, indicating that its longer half-life in serum (1.7 h) compared with that of cefotaxime (approximately 1 h) compensates for its slightly lower microbiologic activity against the penicillin-resistant pneumococci tested in this study.
在一项涉及12名健康志愿者的随机交叉研究中,在两个不同的周末,每12小时静脉注射1克头孢唑肟或头孢噻肟,共注射三剂。针对三株对青霉素具有中度耐药性的肺炎链球菌临床分离株,测定血清杀菌效价(SBT)大于1:2的持续时间以及血清药物浓度保持高于最低抑菌浓度(T>MIC)的时间。两种抗菌药物的SBT持续时间和T>MIC对所有分离株均超过给药间隔的50%。头孢唑肟的T>MIC在统计学上高于头孢噻肟,这表明其血清半衰期(1.7小时)比头孢噻肟(约1小时)长,弥补了其对本研究中测试的耐青霉素肺炎球菌的微生物活性略低的不足。